-
Innovation Ranking
NewInnovation Ranking – D-Link Corporation
D-Link Corp (DLC) is a communications and internet company in Taiwan. It designs, manufactures, and markets home surveillance, home networking, home automation, wireless, switching, surveillance, and network security products. It also offers accessories such as USB hubs; and network infrastructure solutions such as copper and fiber solutions. DLC provides its consumer, business solutions, and service provider solutions to digital home consumers, small office professionals, small-to-medium-sized businesses, and enterprise environments. It also offers various service provider solutions including home network solutions,...
-
Product Insights
NewLikelihood of Approval Analysis for Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
Overview How likely is it that the drugs in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Overview Adrenoleukodystrophy is a disorder that...
-
Track & Monitor
Innovation in automotive: Multi-link electric powertrains
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Multi-link electric powertrains segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MB-207 in X-Linked SCID
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MB-207 in X-Linked SCID report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MB-207 in X-Linked SCID Drug Details: MB-207 is under development for the...
-
Product Insights
X Linked Retinitis Pigmentosa GTPase Regulator – Drugs In Development, 2023
Global Markets Direct’s X Linked Retinitis Pigmentosa GTPase Regulator provides in depth analysis on X Linked Retinitis Pigmentosa GTPase Regulator targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
National Hwy – A417 Missing Link – Gloucestershire
The A417 Missing Link project involves the widening of the A417 motorway between Brockworth and Cowley to the dual carriageway in Gloucestershire, England, the UK. Equip yourself with the essential tools needed to make informed and profitable decisions with our National Hwy – A417 Missing Link – Gloucestershire report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Leriglitazone Hydrochloride in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Leriglitazone Hydrochloride in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Drug Details: Leriglitazone hydrochloride is under development for...
-
Product Insights
Links Solar Farm
Links Solar Farm is a solar PV project located in England, United Kingdom. The project is owned by Low Carbon Investment Management Ltd and is developed by Links Solar Farm Ltd. The project is at the permitting stage. Empower your strategies with our Links Solar Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PXL-770 in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PXL-770 in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Drug Details: PXL-770 is under development for the treatment...